Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7432 p759-763
23/30 December 2006

This section
Reprint   Photocopy

PDF 370K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 759   760   761   762   763 

759 Consider supplying EHC in advance, says Society Pharmacists can supply emergency hormonal contraception in advance but they must consider the clinical appropriateness of a supply when faced with a request, says the Royal Pharmaceutical Society
PJ 2006;277:759
Full Text

759 S60 Order published; expected to come into force early in 2007 The long-awaited Pharmacists and Pharmacy Technicians Order 2007 has been published as a draft Statutory Instrument
PJ 2006;277:759
Full Text

759 Electronic care records to go ahead with mixed consent model From spring 2007, the electronic summary care record will be implemented in early adopter sites in England but patients will be able to amend records and choose to opt out if they wish, health minister Lord Warner said this week
PJ 2006;277:759
Full Text


760 How to obtain oxygen away from home Arrangements for supplying oxygen to patients from Scotland during visits to England and Wales, and vice versa, are outlined in an NHS circular published by the Scottish Executive this week. Patients need to be aware of the different routes of supply (ie, regional oxygen suppliers in England and Wales, and pharmacies in Scotland)
PJ 2006;277:760
Full Text

760 Welsh school will jointly host burns research centre The UK's first major centre for burns research is to be hosted by the Welsh School of Pharmacy, in partnership with the schools of medicine and dentistry at Cardiff University and Morriston Hospital Swansea
PJ 2006;277:760
Full Text

760 Scottish Drug Tariff changes Changes to the Scottish Drug Tariff have been set out in two NHS circulars published this week
PJ 2006;277:760
Full Text

760 Adjustments to reimbursement/remuneration switch still needed Contractors in Scotland have been told that the transfer of money from reimbursement to remuneration, scheduled to take place in this financial year, might not be completed. Instead, further adjustments could be needed early in the next financial year
PJ 2006;277:760
Full Text

760 NPC launches campaign to improve statin prescribing Resources to support high quality, cost effective prescribing and medicines management of statins are available through an online campaign, launched last week by the National Prescribing Centre
PJ 2006;277:760
Full Text

760 Company law to change with approval of Companies Bill The Companies Bill received Royal Assent last month and introduces changes to simplify and improve UK company law
PJ 2006;277:760
Full Text


761 NPSA to change its focus as part of new patient safety strategy Procedures designed to improve patient safety are to be overhauled next year, including a redesign of the National Patient Safety Agency's National Reporting and Learning System and of the NPSA itself. The recommendations come in “Safety first: a report for patients, clinicians and health care managers”, published by the Department of Health last week as part of a renewed national strategy for patient safety
PJ 2006;277:761
Full Text

761 Delay to conclusions on reimbursement of branded generics The Department of Health is deferring its conclusions on the reimbursement of branded generic drugs, following its consultation on the subject, until after it has received the Office of Fair Trading report on the Pharmaceutical Price Regulation Scheme, expected early in 2007
PJ 2006;277:761
Full Text

761 Reporting systems miss many patient safety incidents Routine incident reporting systems considerably under-report the scale and severity of patient safety incidents, according to research published online in BMJ First last week
PJ 2006;277:761
Full Text

761 Guidance published on primary medical services A guide to primary medical services for potential contractors — including pharmacists — has been published by NHS Primary Care Contracting
PJ 2006;277:761
Full Text


762 Long-term HIV study confirms lack of advantage of three-class strategy for initial antiretroviral therapy For HIV-infected patients, a treatment regimen containing three classes of antiretroviral drugs offers no advantages over a two-class strategy for immunological and clinical outcomes, and is associated with increased toxic effects, data from a long-term trial reveal
PJ 2006;277:762
Full Text

762 Bevacizumab plus chemotherapy improves survival in lung cancer Addition of bevacizumab to a standard platinum-based, two-agent chemotherapy regimen in the treatment of selected patients with non-small-cell lung cancer improves survival but is associated with an increased risk of treatment-related deaths, according to research published
PJ 2006;277:762
Full Text

762 Ertapenem as prophylaxis Ertapenem, a long-acting carbepenem, is more effective than the cephalosporin cefotetan in preventing surgical site infections in patients undergoing elective colorectal surgery, researchers report. However, they warn that ertapenem may be associated with more Clostridium difficile infections
PJ 2006;277:762
Full Text

762 Regulators' review of substance misuse services published Improvements can be made across all areas of community prescribing services for substance misusers, according to a review by the Healthcare Commission and the National Treatment Agency for Substance Misuse
PJ 2006;277:762
Full Text


763 Modest intake of cranberry juice OK with warfarin The significance of an interaction between cranberry juice and warfarin has been called into question by the authors of a recent study
PJ 2006;277:763
Full Text

763 Call for folic acid fortification of flour to be mandatory Mandatory fortification of flour with folic acid in the UK is one of the recommendations made by the Scientific Advisory Committee on Nutrition in its final report on folic acid and disease prevention
PJ 2006;277:763
Full Text

763 Low daily alcohol intake may prevent rheumatoid arthritis Mice ingesting low levels of alcohol on a daily basis have a reduced risk of developing rheumatoid arthritis, researchers report
PJ 2006;277:763
Full Text

Back to Top


©The Pharmaceutical Journal